Sexually transmitted infections (STIs) are an important global health priority because of their devastating impact on women and infants and their inter-relationships with HIV/AIDS biologically and epidemiologically. The ultimate objective of NIAID-supported research is to develop effective prevention and treatment approaches to control STIs.
To advance research to understand and address Herpes Simplex Virus (HSV) infection, the NIH has established a strategic plan for research that combines the efforts of the research community with those in public health and clinical medicine to develop interventions to reduce the health consequences of HSV.
NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential funding for STI research.
Program Officers for STIs can be found in the Enteric and Sexually Transmitted Infections Branch (ESTIB) of the Division of Microbiology and Infectious Diseases (DMID). For information on HSV basic research, see DMID's Virology Branch (VB).
Connect With Other Researchers
Researchers at NIAID
Much of the STI research ongoing at NIAID takes place in these laboratories:
Laboratory of Immunoregulation
- Thomas C. Quinn, M.D., M.Sc., International HIV/STI Section
- Steven J. Reynolds, M.D., M.P.H., International HIV/STI Section
Laboratory of Infectious Diseases
Laboratory of Viral Diseases
Laboratory of Bacteriology
- David (Ted) Hackstadt, Ph.D., Host-Parasite Interactions Section
Laboratory of Clinical Immunology and Microbiology
- Harlan D. Caldwell, Ph.D., Chlamydial Diseases Section
Resources for Researchers
You may request services if you are an investigator in academia, a not-for-profit organization, industry, or government in the United States or worldwide. You need not be a grantee of NIAID or another National Institutes of Health Institute or Center. Look to each resource for further eligibility information.
Current Challenges in Evaluating Antimicrobials for Urogenital Gonorrhea
Experts Collaborate to Design Thorough and Effective Future Trials
February 5-6, 2019